Naturally acquired IgG antibodies to thrombospondin-related anonymous protein of Plasmodium vivax (PvTRAP) in Thailand predominantly elicit immunological cross-reactivity

Tropical Medicine & International Health : TM & IH
Rattiporn KosuwinSomchai Jongwutiwes

Abstract

Thrombospondin-related anonymous protein (TRAP) is a prime candidate for a malaria vaccine. Antibodies to Plasmodium vivax TRAP (PvTRAP) occur upon natural infection while specific antigenic domains remain to be addressed. The PvTRAP sequences were determined from 73 P. vivax isolates from Tak and Ubon Ratchathani provinces collected in 2013. The recombinant proteins representing four variants each for domain II (A domain) and domain IV (thrombospondin repeat region) of PvTRAP circulating in these areas were used as antigens in enzyme-linked immunosorbent assay against 246 serum samples from P. vivax-infected patients in both provinces collected during 2013 and 2014. The prevalence of total IgG antibodies to at least one variant antigen of domain II and domain IV was 63.8% and 71.5%, respectively. Differential IgG antibody responses to these variant antigens of each domain were observed. Total IgG antibody responses to the variant antigens of each domain upon pairwise comparisons were highly correlated, suggesting immunological cross-reactivity in the majority of serum samples. A smaller proportion of serum samples contained non-cross-reactive antibodies to variants of each domain; particularly domain II in which amino acid dif...Continue Reading

References

May 1, 1975·The American Journal of Tropical Medicine and Hygiene·D F Clyde
Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·W O RogersS L Hoffman
Jul 1, 1991·The American Journal of Tropical Medicine and Hygiene·J K BairdS Masbar
Jan 1, 1989·Advances in Immunology·V Nussenzweig, R S Nussenzweig
Apr 4, 2002·The Journal of Infectious Diseases·Stephen L HoffmanThomas L Richie
Sep 13, 2002·Immunology and Cell Biology·Jiraprapa WipasaMichael F Good
Apr 26, 2006·Immunome Research·Jens Erik Pontoppidan LarsenMorten Nielsen
Jun 15, 2007·Memórias do Instituto Oswaldo Cruz·Angélica CastellanosSócrates Herrera
Jun 20, 2008·Nature Immunology·Jean LanghorneKevin Marsh
May 23, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Chaturong PutaporntipAustin L Hughes
Jun 18, 2010·Vaccine·Sofia CasaresThomas L Richie
Dec 3, 2010·The Journal of Clinical Investigation·Peter D CromptonLouis H Miller
May 21, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PutaporntipS Jongwutiwes
Oct 18, 2011·Emerging Infectious Diseases·Somchai JongwutiwesChaturong Putaporntip
Nov 15, 2011·Annual Review of Medicine·Mahamadou A Thera, Christopher V Plowe
Jan 9, 2013·Clinical Microbiology Reviews·J Kevin Baird
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Apr 11, 2014·The Journal of Infectious Diseases·Michael T WhiteAzra C Ghani
Oct 20, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Saeed NazeriSedigheh Zakeri
Dec 15, 2015·Clinical and Vaccine Immunology : CVI·Rhea J LongleyJetsumon Sattabongkot

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.